http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104555980-B

Outgoing Links

Predicate Object
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-616
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C69-157
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C01B31-02
filingDate 2014-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2016-06-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-104555980-B
titleOfInvention A kind of carbon quantum dot based on aspirin and biologic applications thereof
abstract Based on the application of the carbon quantum dot of aspirin and cell imaging and anti-inflammatory treatment aspect, belong to Nano medication technical field。It is specifically related to, when hydrazine hydrate solution promotes that aspirin dissolves, utilize microwave heating method to be prepared into the carbon quantum dot with hyperfluorescence character。Carbon quantum dot prepared by the method is highly stable when high salt concentration and physiological pH, maintains blue-fluorescence, and can enter nucleus, cell is carried out effective spike;Also retains the original anti-inflammatory efficacy of aspirin simultaneously, in the acute inflammation model utilizing carrageenin to build, can effectively suppress inflammatory cell to produce;Additionally, prepared aspirin carbon quantum dot toxicity is less, liver function, kidney merit and the internal organs such as the heart, liver,spleen,kidney will not be produced impact by application in vivo, it may be achieved nano material has the target of diagnosis and treatment double effects。
priorityDate 2014-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42881
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP0CD61
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419588607
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9H3H5
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07286
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52892
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ10334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137319715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556224
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52894
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP39465
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP52893
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24140
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54MJ7
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP96000
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP34106
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449682174
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ5EA65
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42867
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO64314
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22227373
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451822344
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23338
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24654
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP42864
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9T1W1

Total number of triples: 47.